ArticleAnnals of hematology2026

Very-low-dose decitabine and rhTPO for thrombocytopenia in lower-risk myelodysplastic syndrome.

Zhen Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.